These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 29648579)
1. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway. Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579 [TBL] [Abstract][Full Text] [Related]
2. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399 [TBL] [Abstract][Full Text] [Related]
3. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
4. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955 [TBL] [Abstract][Full Text] [Related]
5. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma. Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433 [TBL] [Abstract][Full Text] [Related]
6. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis. Yu DP; Zhou Y Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025 [TBL] [Abstract][Full Text] [Related]
7. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573 [TBL] [Abstract][Full Text] [Related]
8. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
9. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related]
11. Clusterin plays an important role in clear renal cell cancer metastasis. Wang X; Luo L; Dong D; Yu Q; Zhao K Urol Int; 2014; 92(1):95-103. PubMed ID: 24008723 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
14. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma. Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215 [TBL] [Abstract][Full Text] [Related]
15. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma. He C; Chen ZY; Li Y; Yang ZQ; Zeng F; Cui Y; He Y; Chen JB; Chen HQ BMC Nephrol; 2019 Apr; 20(1):127. PubMed ID: 30975094 [TBL] [Abstract][Full Text] [Related]
16. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression. Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway. Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910 [TBL] [Abstract][Full Text] [Related]
19. Capn4 is a marker of poor clinical outcomes and promotes nasopharyngeal carcinoma metastasis via nuclear factor-κB-induced matrix metalloproteinase 2 expression. Zheng PC; Chen X; Zhu HW; Zheng W; Mao LH; Lin C; Liu JN; Zheng M Cancer Sci; 2014 Jun; 105(6):630-8. PubMed ID: 24703594 [TBL] [Abstract][Full Text] [Related]
20. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling. Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]